Syntal Capital Partners, LLC Abb Vie Inc. Transaction History

Syntal Capital Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $49,028 - $61,013	-370 Reduced 4.43%	7,986 $1.08 Million
Q1 2023 Apr 21, 2023	BUY	$144.61 - $166.54 $42,226 - $48,629	292 Added 3.62%	8,356 $1.33 Million
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $34,992 - $41,965	253 Added 3.24%	8,064 $1.3 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $9,663 - $11,082	72 Added 0.93%	7,811 $1.05 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $1.3 Million - $1.66 Million	-9,464 Reduced 55.01%	7,739 $1.19 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $2.27 Million - $2.82 Million	17,203 New	17,203 $2.79 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Syntal Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Syntal Capital Partners, LLC with notifications on news.